The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening
- PMID: 8104369
The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening
Abstract
The incidence of Duchenne muscular dystrophy (DMD) in Eastern Austria was investigated. From 1968-1983 302,643 boys were born, 68 of whom were subsequently identified as having Duchenne muscular dystrophy. The overall incidence with respect to live male births is 1:4451 (22.5 x 10(-5)). The mean age of the children at the occurrence of the first symptoms was 3.1 (SD 1.1), at first presentation to a physician 4.8 (SD 2.0), and at diagnosis 5.5 (SD 1.7) years. DMD occurred in 56 families. These families had 73 boys with DMD, 5 of whom were born before or after the observation period. Thirteen families had two affected boys and two families even had three. In 4 families a second boy suffering from DMD was born although the diagnosis of DMD had already been established in another close male relative. If a newborn male screening system had been in function, 13 cases could possibly have been avoided. However, since in 3 cases the affected siblings were not both born within the observation period, they were excluded, leaving 10 cases. Hence, a prevention rate of 14.7% might have been achieved through creatine kinase (CK) screening and genetic counselling.
Similar articles
-
[Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)].J Genet Hum. 1987 Aug;35(4):217-30. J Genet Hum. 1987. PMID: 3655748 French.
-
Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.Am J Med Genet. 1991 Apr 1;39(1):68-75. doi: 10.1002/ajmg.1320390115. Am J Med Genet. 1991. PMID: 1867267
-
[Systematic neonatal screening for Duchenne muscular dystrophy].Nouv Presse Med. 1979 Apr 21;8(18):1491-3. Nouv Presse Med. 1979. PMID: 471723 French.
-
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.Hum Genet. 1984;66(1):17-40. doi: 10.1007/BF00275183. Hum Genet. 1984. PMID: 6365739 Review.
-
Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.JAMA Neurol. 2016 Jan;73(1):111-6. doi: 10.1001/jamaneurol.2015.3537. JAMA Neurol. 2016. PMID: 26594870 Review.
Cited by
-
Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.Biomed Res Int. 2014;2014:246195. doi: 10.1155/2014/246195. Epub 2014 Mar 20. Biomed Res Int. 2014. PMID: 24772416 Free PMC article. Review.
-
Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?J Child Neurol. 2018 Jul;33(8):537-545. doi: 10.1177/0883073818773029. Epub 2018 May 15. J Child Neurol. 2018. PMID: 29759004 Free PMC article.
-
Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).Eur J Hum Genet. 2013 Oct;21(10):1049-53. doi: 10.1038/ejhg.2012.301. Epub 2013 Jan 23. Eur J Hum Genet. 2013. PMID: 23340516 Free PMC article.
-
Prevalence of Duchenne and Becker muscular dystrophies in the United States.Pediatrics. 2015 Mar;135(3):513-21. doi: 10.1542/peds.2014-2044. Epub 2015 Feb 16. Pediatrics. 2015. PMID: 25687144 Free PMC article.
-
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.Birth Defects Res A Clin Mol Teratol. 2006 Nov;76(11):793-7. doi: 10.1002/bdra.20279. Birth Defects Res A Clin Mol Teratol. 2006. PMID: 17036307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials